Selected Grants
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults
Clinical TrialPrincipal Investigator · Awarded by Ipsen Innovation · 2023 - 2026New daily persistent headache: Biomarker Study in Children and Adolescents
ResearchCollaborator · Awarded by International Headache Society · 2023 - 2025Migraine Study - Godley Gift
ResearchCo Investigator · Awarded by Frederick Godley, III · 2021 - 2024A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients with Chronic Migraine
Clinical TrialPrincipal Investigator · Awarded by Alder BioPharmaceuticals, Inc. · 2017 - 2018External Relationships
- British Medical Journal
- Ipsen
- Medical Legal work
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.